Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Circulating tumor stem cells and glioblastoma: A review.

van Schaijik B, Wickremesekera AC, Mantamadiotis T, Kaye AH, Tan ST, Stylli SS, Itinteang T.

J Clin Neurosci. 2019 Mar;61:5-9. doi: 10.1016/j.jocn.2018.12.019. Epub 2019 Jan 6. Review.

PMID:
30622004
2.

Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28. Erratum in: Arch Dermatol Res. 2017 Jul;309(5):409.

PMID:
22740085
3.

A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.

Bocci F, Jolly MK, George JT, Levine H, Onuchic JN.

Oncotarget. 2018 Jul 6;9(52):29906-29920. doi: 10.18632/oncotarget.25692. eCollection 2018 Jul 6.

4.

Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.

Okumura T, Yamaguchi T, Watanabe T, Nagata T, Shimada Y.

Adv Exp Med Biol. 2017;994:247-254. doi: 10.1007/978-3-319-55947-6_13. Review.

PMID:
28560678
5.

Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma.

Patel S, Shah K, Mirza S, Daga A, Rawal R.

Curr Stem Cell Res Ther. 2015;10(2):140-52. Review.

PMID:
25330402
6.

Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.

Książkiewicz M, Markiewicz A, Zaczek AJ.

Pathobiology. 2012;79(4):195-208. doi: 10.1159/000337106. Epub 2012 Apr 4. Review.

7.

Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.

Ishiwata T.

Pathol Int. 2016 Nov;66(11):601-608. doi: 10.1111/pin.12447. Epub 2016 Aug 10. Review.

PMID:
27510923
8.

The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.

Marcucci F, Ghezzi P, Rumio C.

Mol Cancer. 2017 Jan 30;16(1):3. doi: 10.1186/s12943-016-0573-8. Review.

9.

EMT, CTCs and CSCs in tumor relapse and drug-resistance.

Mitra A, Mishra L, Li S.

Oncotarget. 2015 May 10;6(13):10697-711. Review.

10.
11.

Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G1-S Phase Progression in Human Glioblastoma Stem Cells.

Peretti M, Raciti FM, Carlini V, Verduci I, Sertic S, Barozzi S, Garré M, Pattarozzi A, Daga A, Barbieri F, Costa A, Florio T, Mazzanti M.

Mol Cancer Ther. 2018 Nov;17(11):2451-2461. doi: 10.1158/1535-7163.MCT-17-1223. Epub 2018 Aug 22.

PMID:
30135216
12.

Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells.

Castellanos JA, Merchant NB, Nagathihalli NS.

Onco Targets Ther. 2013 Sep 13;6:1261-7. doi: 10.2147/OTT.S34670. Review.

13.

Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.

Grover PK, Cummins AG, Price TJ, Roberts-Thomson IC, Hardingham JE.

Ann Oncol. 2014 Aug;25(8):1506-16. doi: 10.1093/annonc/mdu018. Epub 2014 Mar 20. Review.

PMID:
24651410
14.
15.

Cancer Stem Cells in the Thyroid.

Nagayama Y, Shimamura M, Mitsutake N.

Front Endocrinol (Lausanne). 2016 Feb 29;7:20. doi: 10.3389/fendo.2016.00020. eCollection 2016. Review.

16.

Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Neelakantan D, Drasin DJ, Ford HL.

Cell Adh Migr. 2015;9(4):265-76. doi: 10.4161/19336918.2014.972761. Epub 2014 Oct 16. Review.

17.

Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells.

Chandrakesan P, Panneerselvam J, Qu D, Weygant N, May R, Bronze MS, Houchen CW.

J Carcinog Mutagen. 2016 Apr;7(2). pii: 257. Epub 2016 Mar 7.

18.

Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.

Bajetto A, Pattarozzi A, Corsaro A, Barbieri F, Daga A, Bosio A, Gatti M, Pisaturo V, Sirito R, Florio T.

Front Cell Neurosci. 2017 Oct 13;11:312. doi: 10.3389/fncel.2017.00312. eCollection 2017.

19.

Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Martin-Castillo B, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Moreno JM, Corominas-Faja B, Urruticoechea A, Martín ÁG, López-Bonet E, Menendez JA.

Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15.

20.

Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.

Marie-Egyptienne DT, Lohse I, Hill RP.

Cancer Lett. 2013 Nov 28;341(1):63-72. doi: 10.1016/j.canlet.2012.11.019. Epub 2012 Nov 28. Review.

PMID:
23200673

Supplemental Content

Support Center